Fig 14. Monthly follow-up effect of the cost-sharing change on the pharmaceutical consumption: Genitourinary Agents.

The figures contain Difference-in-Difference estimates from linear regression models with robust standard errors with a 95% confidence interval (CI). All regressions include age and age2, and time dummies. We used for the analysis bar graphics with standard errors. The monthly period covers from August 2011 to June 2013; April 2012: April 20th, 2012 was the date on which the reform was announced; July 2012: July 1st, 2012 was the date on which the reform entered into force (date of cost-sharing change). As this therapeutic group does not contain medicines from the list of 426 drugs excluded from public provision, we only provide one model.